Medpace Holdings earnings were $416.4M for the trailing 12 months ending Mar 31, 2025, with 32.8% growth year over year. The latest MEDP earnings report on Mar 31, 2025 announced Q1 2025 earnings of $114.6M, down 2.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MEDP reported annual earnings of $404.4M, with 43% growth. The next MEDP earnings date is Jul 21, 2025.
MEDP past earnings growth
How has MEDP's earnings growth performed historically?
What were Medpace Holdings's earnings last quarter?
On MEDP's earnings call on Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q1 2025 earnings per share (EPS) of $3.77, up 13.55% year over year. Total MEDP earnings for the quarter were $114.60 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $3.32.
The next MEDP earnings call is Invalid Date. Add MEDP to your watchlist to be reminded of Medpace Holdings's next earnings date.
Is Medpace Holdings profitable or losing money?
As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $416.39 million, a 33.24% increase year over year.
What was MEDP's earnings growth in the past year?
As of Medpace Holdings's earnings date in Invalid Date, Medpace Holdings's earnings has grown 32.84% year over year. This is 28.94 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 3.9%. MEDP earnings in the past year totalled $416.39 million.
What are Medpace Holdings's earnings expectations?
The current EPS estimate for Medpace Holdings's earnings report in Invalid Date is $2.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.